Literature DB >> 2058177

Comparative enantioselectivity in the sulphoxidation of albendazole in man, dogs and rats.

P Delatour1, E Benoit, S Besse, A Boukraa.   

Abstract

1. H.p.l.c. analyses were performed to investigate the plasma kinetics of albendazole (ABZ), the sulphoxide (SO.ABZ) and sulphone (SO2ABZ) metabolites, as well as the chirality vs time of SO.ABZ, after oral administration to rats, dogs and man of prochiral sulphide antiparasitic drug ABZ. 2. In all three species the initial plasma concentration ratio of the enantiomers, as soon as SO.ABZ could be detected in plasma, was that of a racemate. 3. Subsequently, the ratio (+)/(-) increased linearly with time, reaching values of 13.1 and 9.3 in man and dogs, respectively, while it decreased to 0.6 in rats. 4. The (+) enantiomer represents 80%, 70% and 41% of the area under the curve of the total SO.ABZ in man, dogs and rats, respectively.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2058177     DOI: 10.3109/00498259109039463

Source DB:  PubMed          Journal:  Xenobiotica        ISSN: 0049-8254            Impact factor:   1.908


  9 in total

1.  Pharmacokinetics of ricobendazole after its intravenous, intraruminal and subcutaneous administration in sheep.

Authors:  E A Formentini; N Mestorino; J O Errecalde
Journal:  Vet Res Commun       Date:  2005-10       Impact factor: 2.459

2.  Progress in the pharmacological treatment of human cystic and alveolar echinococcosis: Compounds and therapeutic targets.

Authors:  Mar Siles-Lucas; Adriano Casulli; Roberto Cirilli; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2018-04-20

3.  Enantiomerical pharmacokinetic prevalence of (+) albendazole sulphoxide in Trichinella spiralis muscle larvae.

Authors:  Juan José García-Rodríguez; María Carmen Del Vegas-Sánchez; Juan José Torrado-Durán; Francisco Bolás-Fernández
Journal:  Parasitol Res       Date:  2011-08-16       Impact factor: 2.289

4.  Plasma disposition and faecal excretion of netobimin metabolites and enantiospecific disposition of albendazole sulphoxide produced in ewes.

Authors:  C Gokbulut; V Y Cirak; B Senlik
Journal:  Vet Res Commun       Date:  2006-10       Impact factor: 2.459

5.  Pharmacokinetic behaviour of albendazole sulphoxide enantiomers in male and female sheep.

Authors:  B P Capece; G Castells; F Pérez; M Arboix; C Cristòfol
Journal:  Vet Res Commun       Date:  2000-07       Impact factor: 2.459

6.  Enantioselective distribution of albendazole metabolites in cerebrospinal fluid of patients with neurocysticercosis.

Authors:  O M Takayanagui; P S Bonato; S A C Dreossi; V L Lanchote
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

Review 7.  Pharmacokinetic optimisation of the treatment of neurocysticercosis.

Authors:  J Sotelo; H Jung
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

8.  Determination of albendazole and metabolites in silkworm Bombyx mori hemolymph by ultrafast liquid chromatography tandem triple quadrupole mass spectrometry.

Authors:  Li Li; Dong-Xu Xing; Qing-Rong Li; Yang Xiao; Ming-Qiang Ye; Qiong Yang
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

9.  Comparison of Albendazole Cytotoxicity in Terms of Metabolite Formation in Four Model Systems.

Authors:  Lidia Radko; Maria Minta; Piotr Jedziniak; Sylwia Stypuła-Tręba
Journal:  J Vet Res       Date:  2017-09-19       Impact factor: 1.744

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.